Skip to main content

Want a detailed portfolio tracker?

Ernexa Therapeutics (ERNA) P/E (2022 - 2026)

Ernexa Therapeutics (ERNA) P/E from Mar 31, 2022 to Jul 21, 2026. The TTM Ernexa Therapeutics (ERNA) P/E is -0.19. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Ernexa Therapeutics (ERNA)

YearP/EChange
2026-0.19-10.17%
2025-0.21-61.61%
2024-0.55-94.18%
2023-9.45-34.79%
2022-14.50N/A

Comparison Ernexa Therapeutics (ERNA) P/E with competitors

Ernexa Therapeutics (ERNA) P/E is -0.19.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.90%
NBYStablecoin Development Corp0.00-102.27%
ENLVEnlivex Ltd0.07-139.45%
FGENFibroGen Inc0.24-226.59%
CHRSCoherus Biosciences Inc0.85-547.47%
FBIOFortress Biotech Inc0.95-600.47%
ORMPOramed Pharmaceuticals Inc1.50-892.64%
AGENAgenus Inc3.01-1687.12%
INVAInnoviva Inc3.15-1763.27%
VXRTVaxart Inc3.55-1971.95%
CRMDCorMedix Inc3.63-2013.46%
CVACCureVac N.V.4.45-2444.43%
GLPGGalapagos NV4.86-2662.33%
SRPTSarepta Therapeutics Inc4.88-2674.57%
ABEOAbeona Therapeutics Inc5.39-2941.10%
ABUSArbutus Biopharma Corp5.60-3050.85%
ZVRAZevra Therapeutics Inc5.89-3204.63%
SPROSpero Therapeutics Inc6.23-3384.57%
CGENCompugen Ltd6.31-3429.66%
RIGLRigel Pharmaceuticals6.87-3723.98%
SLXNSilexion Therapeutics Corp7.30-3947.59%
OMEROmeros Corporation9.26-4982.61%
AUPHAurinia Pharmaceuticals Inc9.58-5154.64%
PLXProtalix BioTherapeutics Inc10.89-5843.38%
ACADAcadia Pharmaceuticals Inc11.73-6285.05%
TBPHTheravance Biopharma Inc12.26-6566.46%
ADMAAdma Biologics Inc12.42-6648.73%
HRMYHarmony Biosciences Holdings Inc13.82-7388.10%
SABSSAB Biotherapeutics Inc14.14-7554.75%
NAGENiagen Bioscience Inc14.82-7914.36%
INCYIncyte Corp15.82-8444.06%
REGNRegeneron Pharmaceuticals Inc15.86-8462.04%
PBYIPuma Biotechnology Inc17.32-9231.47%
CPRXCatalyst Pharmaceuticals Inc17.44-9296.66%
EXELExelixis Inc17.54-9348.71%
TGTXTG Therapeutics Inc18.97-10101.79%
MDXGMimedx Group Inc20.55-10938.41%
XOMAXOMA Royalty Corp22.87-12163.34%
ARGXArgen X SE24.30-12913.94%
CTMXCytomX Therapeutics Inc24.82-13189.81%
XOMAOXOMA Royalty Corp25.34-13465.99%
HALOHalozyme Therapeutics Inc25.62-13613.08%
XOMAPXOMA Royalty Corp25.67-13637.55%
VRTXVertex Pharmaceuticals Inc27.99-14863.47%
RPRXRoyalty Pharma plc - Class A28.69-15228.84%
SLNOSoleno Therapeutics Inc29.02-15401.71%
ASNDAscendis Pharma A/S30.09-15966.10%
LGNDLigand Pharmaceuticals Inc - Class B37.91-20093.51%
APLSApellis Pharmaceuticals Inc39.02-20678.47%
BMRNBiomarin Pharmaceutical Inc42.21-22361.10%
KRYSKrystal Biotech Inc45.34-24012.61%
ONCBeiGene Ltd69.54-36773.29%
PHARPharming Group N.V.75.03-39665.97%
TECHBio-Techne Corp101.96-53869.43%
VCELVericel Corp109.92-58068.83%
ALNYAlnylam Pharmaceuticals Inc117.96-62310.84%
GMABGenmab140.29-74084.65%
TLXTelix Pharmaceuticals Ltd162.15-85613.97%
CORTCorcept Therapeutics Inc212.86-112353.92%